Bio-Techne (MIL:1TECH) Total Liabilities: €402 Mil (As of Mar. 2026)


MIL:1TECH Bio-Techne Corp MIL:1TECH
60 GF Score
Price €62.06
GF Value €77.08
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Total Liabilities?

Bio-Techne MIL:1TECH 60 Total Liabilities is €402 Mil as of Mar. 2026. GuruFocus rates MIL:1TECH with a GF Score™ of 60/100 and a GF Value™ of €77.08 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Bio-Techne's Total Liabilities for the quarter that ended in Mar. 2026 was €402 Mil.

Bio-Techne's quarterly Total Liabilities declined from Sep. 2025 (€477.41 Mil) to Dec. 2025 (€437.00 Mil) and declined from Dec. 2025 (€437.00 Mil) to Mar. 2026 (€402.48 Mil).

Bio-Techne's annual Total Liabilities declined from Jun. 2023 (€620.42 Mil) to Jun. 2024 (€589.93 Mil) and declined from Jun. 2024 (€589.93 Mil) to Jun. 2025 (€554.07 Mil).

Bio-Techne Total Liabilities Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Total Liabilities Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 574.13 561.73 620.42 589.93 554.07

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 579.27 554.07 477.41 437.00 402.48
MIL:1TECH
60GF Score
Bio-Techne Corp MIL:1TECH
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bio-Techne's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=152.461+(372.775+23.48
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+5.349+0+0)
=554

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=2217.672-1663.607
=554

Bio-Techne's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=132.585+(238.862+18.743
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+12.292+0+0)
=402

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2206.27-1803.788
=402

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €402 Mil mean?
Bio-Techne (MIL:1TECH) has a Total Liabilities of €402 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bio-Techne and its competitors.
Is Bio-Techne's Total Liabilities too high?
Bio-Techne's current Total Liabilities is €402 Mil. Overall, Bio-Techne has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Total Liabilities compare to ARWR and CYTK?
Bio-Techne's Total Liabilities of €402 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bio-Techne and its competitors. Bio-Techne's current Total Liabilities is €402 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Based on GuruFocus' analysis, Bio-Techne (MIL:1TECH) is currently considered Modestly Undervalued. The stock's GF Value™ is €77.08, compared to a current price of €62.06 — trading 19.5% below its estimated fair value. The current Total Liabilities is €402 Mil. Bio-Techne's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bio-Techne (MIL:1TECH), the current Total Liabilities is €402 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MIL:1TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of €62.06 is trading 19.5% below its estimated GF Value™ of €77.08. GuruFocus considers Bio-Techne to be Modestly Undervalued.

Key valuation signals for MIL:1TECH:

  • Total Liabilities: €402 Mil
  • GF Value™: €77.08 vs. price of €62.06 (19.5% below fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the MIL:1TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
60GF Score

Get the complete analysis for MIL:1TECH

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€62.06
Price
€77.08
GF Value